Premium
Endoscopic treatment of Barrett's esophagus: What can we learn from the Western perspective?
Author(s) -
Shimamura Yuto,
Iwaya Yugo,
Goda Kenichi,
Teshima Christopher W.
Publication year - 2018
Publication title -
digestive endoscopy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.5
H-Index - 56
eISSN - 1443-1661
pISSN - 0915-5635
DOI - 10.1111/den.12950
Subject(s) - medicine , radiofrequency ablation , context (archaeology) , esophagus , endoscopic treatment , endoscopic mucosal resection , barrett's esophagus , general surgery , endoscopy , surgery , ablation , cancer , adenocarcinoma , paleontology , biology
The incidence of Barrett's esophagus (BE)‐related neoplasia in Western countries has increased in the past several decades and, even in Eastern countries, it appears to be increasing. Endoscopic therapies are the first‐line treatment for BE‐related neoplasia; however, there is still no standardized treatment strategy. Most of the data have been published from Western countries where the ultimate goal of treatment is complete eradication of BE mucosa removing subtle synchronous lesions and preventing metachronous neoplasia. A multimodality approach that combines endoscopic resection and radiofrequency ablation (RFA) has been widely accepted in the West. In contrast, the lack of access to RFA treatment in the East has meant that endoscopic resection is the only feasible option. There is a wide divergence in treatment strategies for BE‐related neoplasia between the East and the West. It is very important to consider these basic differences in the context of the currently available evidence to date. Therefore, the purpose of this article is to review the recent literature and to provide an overview of the endoscopic treatment options for BE.